StreetInsider

• Log in to your account:

  
  Log in
• Signup
• Home
• EPS Insider
• Event Calendar
• Conferences
• Classic Site

Upgrade to SI Premium - Free Trial

Cumberland Pharmaceuticals (CPIX)

Form 8-K CUMBERLAND PHARMACEUTICA For: Jul 13 July 13, 2026 5:28 PM - SEC Filing Cumberland Pharmaceuticals declares $1.50 special dividend after Apotex deal July 13, 2026 11:00 AM - StreetInsider CUMBERLAND PHARMACEUTICALS ANNOUNCES SPECIAL DIVIDEND OF $1.50 PER SHARE July 13, 2026 10:47 AM - PR NewsWire Form 8-K CUMBERLAND PHARMACEUTICA For: Jun 29 July 1, 2026 4:16 PM - SEC Filing Cumberland Pharmaceuticals sells branded drug line to Apotex for $100M July 1, 2026 9:02 AM - StreetInsider Cumberland Pharmaceuticals Closes Strategic Transaction with Apotex July 1, 2026 9:00 AM - PR NewsWire Cumberland Pharmaceuticals shares updated DMD cardiac trial data June 26, 2026 11:01 AM - StreetInsider Cumberland Pharmaceuticals Shares Updated FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference June 26, 2026 11:00 AM - PR NewsWire Form 8-K CUMBERLAND PHARMACEUTICA For: Jun 24 June 25, 2026 5:01 PM - SEC Filing RedHill Biopharma closes $6M private placement with warrant upside June 22, 2026 4:10 PM - StreetInsider RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement June 22, 2026 4:10 PM - PR NewsWire RedHill Biopharma sets $6M private placement with warrant upside June 18, 2026 8:00 AM - StreetInsider RedHill Biopharma Announces Up To $19.4 Million Private Placement June 18, 2026 8:00 AM - PR NewsWire RedHill initiates enforcement of $10.9 million judgment in Korea June 8, 2026 7:01 AM - StreetInsider RedHill Launches Enforcement of $11 Million New York Supreme Court Final Judgment Against Kukbo June 8, 2026 7:00 AM - PR NewsWire Cumberland reports positive cancer trial results for ifetroban drug June 2, 2026 9:06 AM - StreetInsider Cumberland Pharmaceuticals and Vanderbilt Health Announce Potential New Therapy to Prevent Cancer Metastasis June 2, 2026 9:05 AM - PR NewsWire RedHill explores opaganib for ebola outbreak response June 2, 2026 8:00 AM - StreetInsider RedHill Biopharma Advancing Opaganib Options for Novel Dual Host Directed and Direct Acting Antiviral Approach for Ebola Outbreak Biodefense Platforms June 2, 2026 8:00 AM - PR NewsWire CUMBERLAND PHARMACEUTICALS ANNOUNCES LAUNCH OF VIBATIV® IN CHINA May 28, 2026 9:05 AM - PR NewsWire Form DEFM14A CUMBERLAND PHARMACEUTICA May 26, 2026 6:04 AM - SEC Filing Form PREM14A CUMBERLAND PHARMACEUTICA For: May 15 May 15, 2026 4:33 PM - SEC Filing Form 10-Q CUMBERLAND PHARMACEUTICA For: Mar 31 May 8, 2026 5:02 PM - SEC Filing Cumberland Pharmaceuticals (CPIX) Reports Q1 Loss of $0.13 May 5, 2026 5:29 PM - StreetInsider Form 8-K CUMBERLAND PHARMACEUTICA For: May 05 May 5, 2026 5:07 PM - SEC Filing CUMBERLAND PHARMACEUTICALS REPORTS Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE May 5, 2026 5:00 PM - PR NewsWire RedHill's RHB-204 shows comparable efficacy to RHB-104 in lab tests April 30, 2026 7:03 AM - StreetInsider RedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohn's Disease April 30, 2026 7:00 AM - PR NewsWire CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE April 28, 2026 4:05 PM - PR NewsWire RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights April 27, 2026 8:00 AM - PR NewsWire Form 8-K CUMBERLAND PHARMACEUTICA For: Apr 21 April 24, 2026 5:08 PM - SEC Filing Full Article List